Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 2,052.00p on 13-03-2026 at 14:21:06
Change 21.00p 1.03%
Buy 2,052.00p
Sell 2,051.00p
Last Trade: Buy 40.00 at 2,052.00p
Day's Volume: 4,221,841
Last Close: 2,031.00p
Open: 2,029.00p
ISIN: GB00BN7SWP63
Day's Range 2,027.00p - 2,062.00p
52wk Range: 1,242.50p - 2,282.00p
Market Capitalisation: £82.21b
VWAP: 2,034.90794p
Shares in Issue: 4.01b

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 40 2,052.00p Automatic Execution
14:20:50 - 13-Mar-26
Buy* 98 2,052.00p Automatic Execution
14:20:50 - 13-Mar-26
Buy* 231 2,052.00p SI Trade
14:20:35 - 13-Mar-26
Unknown* 0 2,049.00p SI Trade
14:19:53 - 13-Mar-26
Buy* 2 2,051.00p SI Trade
14:19:45 - 13-Mar-26
Buy* 194 2,051.00p Automatic Execution
14:19:28 - 13-Mar-26
Buy* 2,375 2,051.00p Automatic Execution
14:19:27 - 13-Mar-26
Buy* 22 2,051.00p Automatic Execution
14:19:25 - 13-Mar-26
Buy* 31 2,051.00p Automatic Execution
14:19:25 - 13-Mar-26
Buy* 21 2,051.00p Automatic Execution
14:19:25 - 13-Mar-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
13th Mar 2026 (Fri) 2,029.00 2,062.00 2,027.00 2,031.00 4,221,841
12th Mar 2026 (Thu) 2,053.00 2,057.00 2,015.00 2,031.00 7,904,164
11th Mar 2026 (Wed) 2,063.00 2,077.00 2,046.00 2,066.00 4,932,959
10th Mar 2026 (Tue) 2,067.00 2,085.00 2,052.00 2,064.00 9,406,603
9th Mar 2026 (Mon) 1,994.00 2,051.00 1,987.50 2,046.00 9,595,185
6th Mar 2026 (Fri) 2,080.00 2,080.00 2,028.00 2,038.00 5,641,142
5th Mar 2026 (Thu) 2,114.00 2,135.00 2,072.00 2,076.00 8,766,502
4th Mar 2026 (Wed) 2,125.00 2,149.00 2,110.00 2,115.00 6,322,356
3rd Mar 2026 (Tue) 2,165.00 2,171.00 2,115.00 2,122.00 6,689,092
2nd Mar 2026 (Mon) 2,194.00 2,196.00 2,168.00 2,180.00 6,965,200
27th Feb 2026 (Fri) 2,166.00 2,201.00 2,153.00 2,201.00 14,107,273
26th Feb 2026 (Thu) 2,196.00 2,211.00 2,154.00 2,167.00 7,370,581
25th Feb 2026 (Wed) 2,182.00 2,217.00 2,176.00 2,214.00 11,628,452
24th Feb 2026 (Tue) 2,194.00 2,218.00 2,176.00 2,201.00 6,378,038
23rd Feb 2026 (Mon) 2,206.00 2,214.00 2,183.00 2,206.00 6,741,406
20th Feb 2026 (Fri) 2,237.00 2,243.00 2,200.00 2,213.00 33,732,693
19th Feb 2026 (Thu) 2,252.00 2,264.00 2,216.00 2,226.00 12,562,351
18th Feb 2026 (Wed) 2,243.00 2,282.00 2,243.00 2,268.00 13,280,520
17th Feb 2026 (Tue) 2,194.00 2,259.00 2,189.00 2,239.00 9,155,075
16th Feb 2026 (Mon) 2,172.00 2,187.00 2,153.00 2,184.00 8,105,053
13th Feb 2026 (Fri) 2,170.00 2,171.00 2,137.00 2,165.00 13,836,859
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
12th Mar 2026 7:00 am RNS Transaction in Own Shares
11th Mar 2026 7:00 am RNS Transaction in Own Shares
11th Mar 2026 7:00 am RNS Transaction in Own Shares
10th Mar 2026 7:00 am RNS Transaction in Own Shares
9th Mar 2026 3:00 pm RNS Board Committee Change
9th Mar 2026 3:00 pm RNS Board Committee Change
9th Mar 2026 7:00 am RNS GSK and Alfasigma agree global linerixibat rights
9th Mar 2026 7:00 am RNS Transaction in Own Shares
6th Mar 2026 2:21 pm RNS Filing of GSK plc 2025 Annual Report on Form 20-F
6th Mar 2026 7:00 am RNS Transaction in Own Shares
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

GSK RSV vaccine secures age indication expansion from US FDA

13th Mar 2026 11:02

(Alliance News) - GSK PLC on Friday said its respiratory syncytial virus vaccine, Arexvy, has gained an age indication expansion from the US Food & Drug Administration. Read More

GSK and Alfasigma ink agreement for worldwide rights for linerixibat

9th Mar 2026 09:01

(Alliance News) - GSK PLC on Monday announced a global licence deal with Alfasigma Spa for the worldwide rights for linerixibat, an investigational treatment for cholestatic pruritus in primary biliary cholangitis. Read More

LONDON BRIEFING: Astra drug wins US review as oil surges above USD100

9th Mar 2026 08:02

(Alliance News) - AstraZeneca secures US priority review for Enhertu, GSK agrees linerixibat deal with Alfasigma, while AdvancedAdvT rules out M&C Saatchi bid. Read More

TRADING UPDATES: Rosebank fundraise; Surface Transforms loses GM deal

3rd Mar 2026 22:22

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

LONDON BROKER RATINGS: Price targets raised for BP and Shell

2nd Mar 2026 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,319.85
Change14.70

Login to your account

Forgot Password?

Not Registered